Remote MCP server to run your Atako AI agents: chat, projects, files, integrations and channels.
- Passed: Handshake
- Passed: Tools listed
- Passed: Updated recently
Median latency 132 ms · Last checked
Explore
Evidence for your next connection.
Independent measurements of remote MCP servers. Every observation has a timestamp.
Read-only probesMCP server · Code & DevOps
Whether a drug has a marketed generic today, and when its Orange Book protections lapse
2 failed · 8 not measured
Median of successful probes over 7 days
Share of countable probes over 30 days, including daily rollups. Auth challenges are excluded.
Tool definitions returned by this server
Independent monitoring
Responded
The server completed its last measured handshake. This is an observation, not a guarantee.
Last checked| Test area | Passed | Failed | Unmeasured |
|---|---|---|---|
ConnectionCan a client connect and discover tools? | 4 | 1 | 0 |
Reliability & speedDoes it respond consistently and quickly? | 0 | 0 | 4 |
Access & authenticationWhat is required to use this server? | 1 | 0 | 2 |
Tool qualityAre the tool definitions usable by an agent? | 3 | 1 | 0 |
Publisher identityCan the publisher be traced to its source? | 4 | 0 | 2 |
Unmeasured means there is not enough evidence to decide. How these checks work
Start using io.github.builtforai/generic-timeline
Choose your client, copy the configuration, then enable the server in your client’s MCP settings.
Run this command in your terminal, then restart Claude Code.
Claude Code
claude mcp add --transport http io-github-builtforai-generic-timeline https://rxinfo.ai/mcpCapabilities
For a US prescription drug, report whether a real MARKETED generic exists today — judged on CMS NADAC price dispersion across NDCs of one drug identity, not on FDA approval counts, because an approved generic that nobody sells does not lower anyone's price. Returns the price range for the identical pill when a generic is marketed, and when one is not, the earliest expiry among listed FDA Orange Book patents and exclusivities. NEVER presents a patent expiry as a launch date. Pediatric exclusivity (21 U.S.C. 355a) is honoured, which moves some dates six months later than naive de-duplication produces.
DiscoveredRecent measurements
| Checked | Result | Response | Tools |
|---|---|---|---|
| Connected | 98 ms | 1 |